Introducing Braining-physical exercise as adjunctive therapy in psychiatric care: a retrospective cohort study of a new method.
Anxiety
Bipolar disorder
Cardiovascular disease
Depression
Exercise
Metabolic disease
Physical Activity on Prescription
Physical activity
Psychiatric care
Psychiatry
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
07 08 2023
07 08 2023
Historique:
received:
24
05
2023
accepted:
25
07
2023
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Patients with severe mental disorders suffer from higher rates of poor somatic health and have shorter life expectancy than the average population. Physical activity can treat and prevent several diseases, e.g. cardiovascular and metabolic disorders as well as psychiatric symptoms. It is therefore of utmost importance to develop effective methods to integrate physical activity into psychiatric care. To meet this need, the physical activity intervention Braining was developed. This study aims to describe Braining, to assess the number of patients reached during the first years of pilot testing, to analyze clinical data in the group of patients participating in Braining 2017-2020 and to assess the intervention. In this descriptive retrospective study we analyzed data from all patients participating in Braining training sessions ≥ 3 times (n = 239), the Braining Participants. Regular patients at the clinic served as a comparison. Furthermore, medical records were studied for a smaller cohort (n = 51), the Braining Pilot Cohort. Data was analyzed using Chi-square and Fisher's tests. During the introduction period of Braining, 580 patients attended an information meeting about Braining, or at least one training session. 239 patients participated in ≥ 3 training sessions, considered to be participants of Braining. These Braining Participants (n = 239), ages 19 to 82, males 23.4%, attended between 3 and 308 training sessions (median 9). The main diagnoses were affective and anxiety disorders. Number of diagnoses ranged from 0 to 10 (median = 2). For the subsample, the Braining Pilot Cohort (n = 51), participants attended between 3 and 208 training sessions (median = 20). Twelve percent were working full-time, and symptom severity of depression and general anxiety was moderate. Two thirds had ≥ 3 different classes of medication. Regarding metabolic morbidity, 28 had been diagnosed with hypertension, though blood lipids, blood glucose as well as blood pressure were within the normal range. Thirty-seven percent were prescribed Physical Activity on Prescription during 2017-2020. One severe adverse event was reported. The Braining intervention reached all age-groups and patients with a wide and representative diagnostic panorama, suggesting that Braining could be a promising and safe method for implementing physical activity in a psychiatric patient population.
Sections du résumé
BACKGROUND
Patients with severe mental disorders suffer from higher rates of poor somatic health and have shorter life expectancy than the average population. Physical activity can treat and prevent several diseases, e.g. cardiovascular and metabolic disorders as well as psychiatric symptoms. It is therefore of utmost importance to develop effective methods to integrate physical activity into psychiatric care. To meet this need, the physical activity intervention Braining was developed. This study aims to describe Braining, to assess the number of patients reached during the first years of pilot testing, to analyze clinical data in the group of patients participating in Braining 2017-2020 and to assess the intervention.
METHODS
In this descriptive retrospective study we analyzed data from all patients participating in Braining training sessions ≥ 3 times (n = 239), the Braining Participants. Regular patients at the clinic served as a comparison. Furthermore, medical records were studied for a smaller cohort (n = 51), the Braining Pilot Cohort. Data was analyzed using Chi-square and Fisher's tests.
RESULTS
During the introduction period of Braining, 580 patients attended an information meeting about Braining, or at least one training session. 239 patients participated in ≥ 3 training sessions, considered to be participants of Braining. These Braining Participants (n = 239), ages 19 to 82, males 23.4%, attended between 3 and 308 training sessions (median 9). The main diagnoses were affective and anxiety disorders. Number of diagnoses ranged from 0 to 10 (median = 2). For the subsample, the Braining Pilot Cohort (n = 51), participants attended between 3 and 208 training sessions (median = 20). Twelve percent were working full-time, and symptom severity of depression and general anxiety was moderate. Two thirds had ≥ 3 different classes of medication. Regarding metabolic morbidity, 28 had been diagnosed with hypertension, though blood lipids, blood glucose as well as blood pressure were within the normal range. Thirty-seven percent were prescribed Physical Activity on Prescription during 2017-2020. One severe adverse event was reported.
CONCLUSIONS
The Braining intervention reached all age-groups and patients with a wide and representative diagnostic panorama, suggesting that Braining could be a promising and safe method for implementing physical activity in a psychiatric patient population.
Identifiants
pubmed: 37550641
doi: 10.1186/s12888-023-05053-8
pii: 10.1186/s12888-023-05053-8
pmc: PMC10405422
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
566Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Malays J Med Sci. 2020 Oct;27(5):5-23
pubmed: 33154698
Br J Sports Med. 2020 Sep;54(18):1073-1080
pubmed: 31563884
BMC Health Serv Res. 2018 Jul 16;18(1):559
pubmed: 30012142
Eur Psychiatry. 2018 Oct;54:124-144
pubmed: 30257806
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
Pharmacoeconomics. 2015 Nov;33(11):1137-54
pubmed: 26040242
Bipolar Disord. 2015 Jun;17(4):424-37
pubmed: 25495748
Psychiatry Res. 1997 Dec 5;73(3):159-71
pubmed: 9481807
Behav Res Ther. 2009 Nov;47(11):902-9
pubmed: 19664756
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
J Psychiatr Res. 2009 Aug;43(12):1013-7
pubmed: 19289240
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Acta Psychiatr Scand. 2021 Sep;144(3):259-276
pubmed: 33960396
Prev Med. 2016 Oct;91:123-131
pubmed: 27514246
Depress Anxiety. 2015 Aug;32(8):624-34
pubmed: 25899389
Med Sci Sports Exerc. 2019 May;51(5):962-969
pubmed: 30531490
Behav Res Ther. 2015 Sep;72:9-17
pubmed: 26159908
J Occup Health. 2017 Nov 25;59(6):477-494
pubmed: 28993574
BMC Psychiatry. 2019 Jun 10;19(1):170
pubmed: 31182060
Adv Exp Med Biol. 2020;1228:3-22
pubmed: 32342447
Neurosci Biobehav Rev. 2023 Sep;152:105257
pubmed: 37263531
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004366
pubmed: 22786489
J Affect Disord. 2020 Mar 15;265:395-401
pubmed: 32090765
Horm Mol Biol Clin Investig. 2018 Jan 10;36(1):
pubmed: 29320364
J Sports Med Phys Fitness. 2022 Apr;62(4):560-567
pubmed: 33721985
Am J Psychiatry. 2018 Jul 1;175(7):631-648
pubmed: 29690792
BMJ. 2019 Aug 21;366:l4570
pubmed: 31434697
Psychiatr Clin North Am. 2010 Sep;33(3):537-55
pubmed: 20599132
J Affect Disord. 2016 Sep 15;202:67-86
pubmed: 27253219
J Ment Health. 2021 Jan 25;:1-9
pubmed: 33487094
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
J Psychiatr Res. 2016 Jun;77:42-51
pubmed: 26978184
Cochrane Database Syst Rev. 2013 Sep 12;(9):CD004366
pubmed: 24026850
Front Psychol. 2020 May 06;11:857
pubmed: 32435223
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):643-677
pubmed: 34873635
J Affect Disord. 2008 Apr;107(1-3):217-20
pubmed: 17727960
Adv Exp Med Biol. 2020;1228:271-287
pubmed: 32342464
Prev Med. 2003 Jun;36(6):698-703
pubmed: 12744913
Lancet. 2011 Oct 1;378(9798):1244-53
pubmed: 21846575
Patient Prefer Adherence. 2012;6:369-88
pubmed: 22654508
J Clin Psychopharmacol. 1993 Oct;13(5):327-31
pubmed: 8227491
Psychiatry Res. 2017 Mar;249:102-108
pubmed: 28088704
Cognit Ther Res. 2012 Oct 1;36(5):427-440
pubmed: 23459093
Front Psychol. 2015 Nov 25;6:1713
pubmed: 26635648
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
PLoS One. 2015 Jan 13;10(1):e0115894
pubmed: 25585123
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Br J Sports Med. 2023 Aug;57(16):1049-1057
pubmed: 36731907
J Phys Act Health. 2018 Dec 17;:1-11
pubmed: 30558473
Encephale. 2016 Dec;42(6):553-561
pubmed: 27423475
J Eval Clin Pract. 2008 Dec;14(6):979-83
pubmed: 18462279
Prim Care Companion J Clin Psychiatry. 2010;12(5):
pubmed: 21274359
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004366
pubmed: 18843656
J Affect Disord. 2017 Mar 01;210:139-150
pubmed: 28033521
Br J Sports Med. 2023 Sep;57(18):1203-1209
pubmed: 36796860
Int J Environ Res Public Health. 2020 May 25;17(10):
pubmed: 32466242
Br J Sports Med. 2019 Mar;53(6):383-388
pubmed: 30413421
Basic Clin Pharmacol Toxicol. 2020 Mar;126(3):183-192
pubmed: 31908124
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383